Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value Growth (5y) (2018 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Enterprise Value Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 164.14 Mn | 136.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.27% |
| Sep 30, 2025 | 20.71% |
| Jun 30, 2025 | -12.93% |
| Mar 31, 2025 | -136.20% |
| Dec 31, 2024 | 17.09% |
| Sep 30, 2024 | -98.40% |
| Jun 30, 2024 | 20.00% |
| Mar 31, 2024 | -5.07% |
| Dec 31, 2023 | -91.63% |
| Sep 30, 2023 | -86.07% |
| Jun 30, 2023 | 14.27% |
| Mar 31, 2023 | 46.57% |
| Dec 31, 2022 | -210.08% |
| Sep 30, 2022 | -12.60% |
| Jun 30, 2022 | -211.87% |
| Mar 31, 2022 | -208.68% |
| Dec 31, 2021 | -86.15% |
| Sep 30, 2021 | -41.39% |
| Jun 30, 2021 | -27.51% |
| Mar 31, 2021 | -326.90% |